These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29558515)

  • 1. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
    Zador Z; King AT; Geifman N
    PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
    Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
    Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.
    Yang X; Huang WT; Wu HY; He RQ; Ma J; Liu AG; Chen G
    Oncol Rep; 2019 Apr; 41(4):2241-2253. PubMed ID: 30816547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.
    Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
    Gene; 2019 Jan; 681():15-25. PubMed ID: 30266498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.
    Dalan AB; Gulluoglu S; Tuysuz EC; Kuskucu A; Yaltirik CK; Ozturk O; Ture U; Bayrak OF
    BMC Cancer; 2017 Mar; 17(1):207. PubMed ID: 28327132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression.
    Wrobel G; Roerig P; Kokocinski F; Neben K; Hahn M; Reifenberger G; Lichter P
    Int J Cancer; 2005 Mar; 114(2):249-56. PubMed ID: 15540215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking.
    Chen YT; Xie JY; Sun Q; Mo WJ
    Int J Oncol; 2019 Jan; 54(1):152-166. PubMed ID: 30387840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative proteomic profiles of meningioma subtypes.
    Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
    Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles.
    Kim IW; Jang H; Kim JH; Kim MG; Kim S; Oh JM
    Sci Rep; 2019 Feb; 9(1):2660. PubMed ID: 30804389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma.
    Serna E; Morales JM; Mata M; Gonzalez-Darder J; San Miguel T; Gil-Benso R; Lopez-Gines C; Cerda-Nicolas M; Monleon D
    PLoS One; 2013; 8(6):e67291. PubMed ID: 23840654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
    Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
    Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
    Harmancı AS; Youngblood MW; Clark VE; Coşkun S; Henegariu O; Duran D; Erson-Omay EZ; Kaulen LD; Lee TI; Abraham BJ; Simon M; Krischek B; Timmer M; Goldbrunner R; Omay SB; Baranoski J; Baran B; Carrión-Grant G; Bai H; Mishra-Gorur K; Schramm J; Moliterno J; Vortmeyer AO; Bilgüvar K; Yasuno K; Young RA; Günel M
    Nat Commun; 2017 Feb; 8():14433. PubMed ID: 28195122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of meningiomas.
    Chukwueke UN; Wen PY
    Handb Clin Neurol; 2020; 170():291-302. PubMed ID: 32586501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro testing to a panel of potential chemotherapeutics and current concepts of chemotherapy in benign meningiomas.
    Balik V; Sulla I; Park HH; Sarissky M
    Surg Oncol; 2015 Sep; 24(3):292-9. PubMed ID: 26099192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
    Schulten HJ; Hussein D
    PLoS One; 2019; 14(5):e0215452. PubMed ID: 31083655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
    Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
    Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas.
    Pérez-Magán E; Rodríguez de Lope A; Ribalta T; Ruano Y; Campos-Martín Y; Pérez-Bautista G; García JF; García-Claver A; Fiaño C; Hernández-Moneo JL; Mollejo M; Meléndez B
    Neuro Oncol; 2010 Dec; 12(12):1278-90. PubMed ID: 20685720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.
    Angus SP; Oblinger JL; Stuhlmiller TJ; DeSouza PA; Beauchamp RL; Witt L; Chen X; Jordan JT; Gilbert TSK; Stemmer-Rachamimov A; Gusella JF; Plotkin SR; Haggarty SJ; Chang LS; Johnson GL; Ramesh V;
    Neuro Oncol; 2018 Aug; 20(9):1185-1196. PubMed ID: 29982664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.